BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 19798727)

  • 21. C1-esterase inhibitor reverses functional consequences of superior mesenteric artery ischemia/reperfusion by limiting reperfusion injury and restoring microcirculatory perfusion.
    Lauterbach M; Horstick G; Plum N; Lotz J; Lauterbach E; Weilemann LS; Kempski O
    Shock; 2007 Jan; 27(1):75-83. PubMed ID: 17172984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of classical complement activation attenuates liver ischaemia and reperfusion injury in a rat model.
    Heijnen BH; Straatsburg IH; Padilla ND; Van Mierlo GJ; Hack CE; Van Gulik TM
    Clin Exp Immunol; 2006 Jan; 143(1):15-23. PubMed ID: 16367929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C3a receptor modulation of granulocyte infiltration after murine focal cerebral ischemia is reperfusion dependent.
    Ducruet AF; Hassid BG; Mack WJ; Sosunov SA; Otten ML; Fusco DJ; Hickman ZL; Kim GH; Komotar RJ; Mocco J; Connolly ES
    J Cereb Blood Flow Metab; 2008 May; 28(5):1048-58. PubMed ID: 18197178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mannose-binding lectin promotes local microvascular thrombosis after transient brain ischemia in mice.
    de la Rosa X; Cervera A; Kristoffersen AK; Valdés CP; Varma HM; Justicia C; Durduran T; Chamorro Á; Planas AM
    Stroke; 2014 May; 45(5):1453-9. PubMed ID: 24676774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of C1-inhibitor protein in patients with acute myocardial infarction.
    Diris JH; Hermens WT; Hemker PW; Lagrand WK; Hack CE; van Dieijen-Visser MP
    Clin Pharmacol Ther; 2002 Nov; 72(5):498-504. PubMed ID: 12426513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New insights on the structural/functional properties of recombinant human mannan-binding lectin and its variants.
    Rajagopalan R; Salvi VP; Jensenius JC; Rawal N
    Immunol Lett; 2009 Apr; 123(2):114-24. PubMed ID: 19428558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia.
    De Simoni MG; Storini C; Barba M; Catapano L; Arabia AM; Rossi E; Bergamaschini L
    J Cereb Blood Flow Metab; 2003 Feb; 23(2):232-9. PubMed ID: 12571454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
    Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
    Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rhucin, a recombinant C1 inhibitor for the treatment of hereditary angioedema and cerebral ischemia.
    Longhurst H
    Curr Opin Investig Drugs; 2008 Mar; 9(3):310-23. PubMed ID: 18311668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant Human C1 Esterase Inhibitor for the Management of Adverse Events Related to Intravenous Immunoglobulin Infusion in Patients With Common Variable Immunodeficiency or Polyneuropathy: A Pilot Open-Label Study.
    Melamed IR; Miranda H; Heffron M; Harper JR
    Front Immunol; 2021; 12():632744. PubMed ID: 33737935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor.
    Kerr FK; Thomas AR; Wijeyewickrema LC; Whisstock JC; Boyd SE; Kaiserman D; Matthews AY; Bird PI; Thielens NM; Rossi V; Pike RN
    Mol Immunol; 2008 Feb; 45(3):670-7. PubMed ID: 17709141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic complement inhibition: new developments.
    Emlen W; Li W; Kirschfink M
    Semin Thromb Hemost; 2010 Sep; 36(6):660-8. PubMed ID: 20865643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mannose binding lectin gene deficiency increases susceptibility to traumatic brain injury in mice.
    Yager PH; You Z; Qin T; Kim HH; Takahashi K; Ezekowitz AB; Stahl GL; Carroll MC; Whalen MJ
    J Cereb Blood Flow Metab; 2008 May; 28(5):1030-9. PubMed ID: 18183030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serine protease inhibitor nafamostat given before reperfusion reduces inflammatory myocardial injury by complement and neutrophil inhibition.
    Schwertz H; Carter JM; Russ M; Schubert S; Schlitt A; Buerke U; Schmidt M; Hillen H; Werdan K; Buerke M
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):151-60. PubMed ID: 18670364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C1-inhibitor protects from brain ischemia-reperfusion injury by combined antiinflammatory and antithrombotic mechanisms.
    Heydenreich N; Nolte MW; Göb E; Langhauser F; Hofmeister M; Kraft P; Albert-Weissenberger C; Brede M; Varallyay C; Göbel K; Meuth SG; Nieswandt B; Dickneite G; Stoll G; Kleinschnitz C
    Stroke; 2012 Sep; 43(9):2457-67. PubMed ID: 22744646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia.
    Orsini F; Villa P; Parrella S; Zangari R; Zanier ER; Gesuete R; Stravalaci M; Fumagalli S; Ottria R; Reina JJ; Paladini A; Micotti E; Ribeiro-Viana R; Rojo J; Pavlov VI; Stahl GL; Bernardi A; Gobbi M; De Simoni MG
    Circulation; 2012 Sep; 126(12):1484-94. PubMed ID: 22879370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ischemia-related changes in naive and mutant forms of ubiquitin and neuroprotective effects of ubiquitin in the hippocampus following experimental transient ischemic damage.
    Ahn HC; Yoo KY; Hwang IK; Cho JH; Lee CH; Choi JH; Li H; Cho BR; Kim YM; Won MH
    Exp Neurol; 2009 Nov; 220(1):120-32. PubMed ID: 19666022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New insight into the effects of heparinoids on complement inhibition by C1-inhibitor.
    Poppelaars F; Damman J; de Vrij EL; Burgerhof JG; Saye J; Daha MR; Leuvenink HG; Uknis ME; Seelen MA
    Clin Exp Immunol; 2016 Jun; 184(3):378-88. PubMed ID: 26874675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human C1 inhibitor attenuates liver ischemia-reperfusion injury and promotes liver regeneration.
    Saidi RF; Rajeshkumar B; Shariftabrizi A; Dresser K; Walter O
    J Surg Res; 2014 Apr; 187(2):660-6. PubMed ID: 24433870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of C1 inhibitor on endothelial cell activation in a rat hind limb ischemia-reperfusion injury model.
    Zhang S; Shaw-Boden J; Banz Y; Bongoni AK; Taddeo A; Spirig R; Nolte MW; Cowan PJ; Rieben R
    J Vasc Surg; 2018 Dec; 68(6S):209S-221S.e2. PubMed ID: 29395422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.